BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2007
View Archived Issues
Recent Merck and AstraZeneca patents report new therapeutic agents for metabolic disorders
Read More
Recent patents cover therapeutic agents for inflammatory disorders
Read More
Two phase I studies of PTC-124 in healthy adults completed
Read More
FdCyd and THU studied for treatment of solid tumors
Read More
Novel camptothecin conjugate with promising efficacy and pharmacokinetic profile
Read More
Replacement of regular insulin with Oral-lyn studied in adults, adolescents
Read More
Certolizumab pegol inhibits cytokine production by monocytes
Read More
Preclinical profile of MORAb-009 reported by Morphotek
Read More
Vaccine targeting prostatic acid phosphatase tested in prostate cancer patients
Read More
Promising preclinical profile of STI-1698, a topoisomerase I inhibitor developed at Sigma-Tau
Read More
LX-1031 begins phase Ib study for IBS
Read More
Introgen initiates efficacy analyses of Advexin phase III study
Read More
NS-2359 begins second phase II study for depression
Read More
U.S. development of CollaRx Gentamicin Surgical Implant to open at phase III
Read More
Agensys discover AGS-16 as a novel target for the treatment of kidney cancer
Read More
Exelixis cleared to resume clinical testing of XL-999
Read More
Dosing completed in phase I metastatic melanoma study of Provecta
Read More
Novartis in-licenses CYT002-NicQb for treatment of nicotine addiction
Read More
New data confirm oral bioavailability of AL-309
Read More
PCK-3145 shows evidence of clinical activity in metastatic prostate cancer patients
Read More
Miraxion fails to meet endpoints in phase III Huntington's studies
Read More
Phase IIa results for i.v. cannabinor in postoperative pain
Read More
EpiCeram comparable to Cutivate in treating atopic dermatitis symptoms
Read More
Alitretinoin shows retreatment benefit in chronic hand eczema
Read More
Abbott discontinues development of levosimendan in U.S.
Read More
Singulair approved to prevent exercise-induced bronchoconstriction
Read More
Novel therapeutic agents for atherosclerosis reported in recent Merck and Merck Frosst patents
Read More